Does GOLIMUMAB Cause Mobility decreased? 3,201 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 3,201 reports of Mobility decreased have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 4.6% of all adverse event reports for GOLIMUMAB.
3,201
Reports of Mobility decreased with GOLIMUMAB
4.6%
of all GOLIMUMAB reports
1,556
Deaths
1,760
Hospitalizations
How Dangerous Is Mobility decreased From GOLIMUMAB?
Of the 3,201 reports, 1,556 (48.6%) resulted in death, 1,760 (55.0%) required hospitalization, and 1,625 (50.8%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 3,201 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which GOLIMUMAB Alternatives Have Lower Mobility decreased Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN